bnc105 potential revenues enormous

Hi guys,

Just to get you all a bit excited while we are waiting around for the anouncment regarding BNC105

The following snippet is from Linwar securities page 7

We could be on a Real winner here....

good luck to all

jojo


The potential revenues from BNC105 is enormous. For example, Roche?s
Avastin (for solid tumour cancers) has a cost of treatment running at $8,000
per patient per month or $96K p.a. to treat a number of cancers.
Assuming BNC105 comes to market in FY19 and assuming a time value
adjusted cost per patient of $118K p.a, the annual revenues would be in
excess of $4bn (from just 40,000 patient worldwide) representing royalty
revenues to BNO in one year vastly in excess of BNO?s current market
capitalisation.


http://www.bionomics.com.au/siteFiles/files/Linwar%20Securities%20Report%2025%20July%202011.pdf